DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
about
Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neuronsPhosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neuronsDARPP-32 mediates the actions of multiple drugs of abuseDistinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatumPrior exposure to a behaviorally sensitizing regimen of d-methamphetamine does not alter the striatal dopaminergic damage induced by a neurotoxic regimenNerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brainChronic dopaminergic signaling in the basal ganglia: a damage perspective on kinases and fos-related antigensGrowth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1.GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKADeltaFosB: a sustained molecular switch for addictionNeurogenetics and pharmacology of learning, motivation, and cognitionPhosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.A role for calmodulin-stimulated adenylyl cyclases in cocaine sensitizationAdenosine A2A receptors and basal ganglia physiologyDARPP-32: from neurotransmission to cancerAlterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaMolecular, cellular, and structural mechanisms of cocaine addiction: a key role for microRNAsAmitriptyline improves motor function via enhanced neurotrophin signaling and mitochondrial functions in the murine N171-82Q Huntington disease model.C. elegans dopaminergic D2-like receptors delimit recurrent cholinergic-mediated motor programs during a goal-oriented behaviorAmplification of dopaminergic signaling by a positive feedback loopSignal transduction and genes-to-behaviors pathways in psychiatric diseasesPhosphorylation of DARPP-32 at Threonine-34 is required for cocaine actionLocomotor effects of a D1R agonist are DARPP-32 dependent in adult but not weanling miceAKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitroNeuronal and behavioural abnormalities in striatal function in DARPP-32-mutant miceThe internal state of medium spiny neurons varies in response to different input signalsSegregation and crosstalk of D1 receptor-mediated activation of ERK in striatal medium spiny neurons upon acute administration of psychostimulantsDARPP-32 is a robust integrator of dopamine and glutamate signalsA phosphatase cascade by which rewarding stimuli control nucleosomal response.KEPI, a PKC-dependent protein phosphatase 1 inhibitor regulated by morphineDopamine D(1) receptor-induced gene transcription is modulated by DARPP-32Individual differences in ethanol locomotor sensitization are associated with dopamine D1 receptor intra-cellular signaling of DARPP-32 in the nucleus accumbensDopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32Decreased calcineurin and increased phosphothreonine-DARPP-32 in the striatum of rats behaviorally sensitized to methamphetaminePhosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout miceRegulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2AInhibitor-1 is not required for the activation of glycogen synthase by insulin in skeletal muscle.A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in miceConditional targeting of medium spiny neurons in the striatal matrix.Distribution of protein phosphatases-1 alpha and -1 gamma 1 and the D(1) dopamine receptor in primate prefrontal cortex: Evidence for discrete populations of spines.
P2860
Q21131062-49D8BD2E-C64E-4BA6-9B5D-FC544C79C389Q22010952-906970BB-044C-453E-BFC8-C0DD8D4E6FA1Q22241668-694B0E2C-4BD3-427B-A212-831D67A48DF8Q23909635-C7CF653C-8395-4886-B658-6D776B442357Q23912103-BC5E26A5-D06A-4701-80B4-22854441A091Q23913649-113A4CC9-5128-4705-9332-E87B5020DFA4Q23914341-8C423FCE-3003-4A34-B44A-7A9C708D1EA7Q24291713-09562C8E-D95B-4D11-B114-41F4AA18A782Q24530581-14C1864C-2D09-4513-806C-A3203ABCC5B2Q24555194-C0772EE4-5EC3-45E9-A9B1-0E2C279041DDQ24602643-465EAE83-5CEE-4BF2-8783-804672032293Q24633622-8318FB35-7B1C-4938-B5E6-D7B764708627Q24649092-9F1E9827-119D-4862-8244-685FFD196419Q24669783-12DEFE34-FD5D-40BE-B7B9-EEE0C5D3824AQ26766237-63F30AB8-C962-4E5A-9263-8C796E6A4435Q26773403-764260E5-8CA7-42E1-A625-FD34F7C56763Q27008450-4FE8DC1B-884D-4C54-A14C-2F69D0FE0D61Q27314860-DDFD25AD-0DBA-46F2-873E-1363358892F1Q27330422-D246002A-726A-4884-B739-AE85D04B893AQ28142174-7FC43D28-8441-49AE-81E5-DAFB68A1F9DBQ28182063-0663619E-10AA-4E30-B285-C9EC1FA4B741Q28269125-63E94344-92C7-4615-8803-2D3EA5152ED0Q28274351-0A448746-8338-4F07-857F-28AAA98EBE0EQ28282315-34A77E32-315C-4353-96BF-A42B84193FDFQ28372752-7F334B50-622F-43B2-A581-3ADA769DDFA5Q28394570-CC0338DF-4F27-4DF9-BAE5-EFED236FD5BCQ28395155-BD156A00-5526-4E63-8455-561A7A8977C7Q28469090-C4563BD2-B0C6-4918-B260-F3E4A6FCB568Q28508656-D5E49249-EA26-4CA4-9356-B9E84EE9F91CQ28509333-CA4BCDB5-9D7C-4272-A702-BB98F1D74143Q28510092-D079F1AE-EEC6-430F-8A08-7711EF2DFDD9Q28539599-A8477790-BA34-4BAD-984B-63C214019B83Q28570233-9F9DF1E0-2209-45BD-B177-0D034F1A1243Q28580808-9D29659B-05F2-44CB-925B-804E0BB338FBQ28586429-78C74838-CE3D-4CE6-ACE1-B47B9CB8C377Q28641016-269C978C-3504-49E3-BD91-C0C306BD299DQ30304137-ABB2804E-87C0-4E70-8753-FF9905F6C226Q30541064-5FCD9446-D369-4EA9-B64C-EE8351886444Q30632650-C5A0EDC0-B9D0-4295-907C-EC718D7C6A20Q30779218-2CBFC01F-2791-4D19-9271-985F0F1F8CE9
P2860
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission
@nl
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@ast
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@en
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@en-gb
type
label
DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission
@nl
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@ast
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@en
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@en-gb
prefLabel
DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission
@nl
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@ast
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@en
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@en-gb
P921
P1433
P1476
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission
@en
P2093
A. A. Fienberg
P2880
P304
P356
10.1126/SCIENCE.281.5378.838
P407
P577
1998-08-07T00:00:00Z